
IOLCP.BO Earnings Date: Oct 30, 2026 (Estimated) — IOL Chemicals and Pharmaceuticals Limited
BSE
Updated
When is IOLCP.BO's next earnings date?
IOL Chemicals and Pharmaceuticals Limited (IOLCP.BO) is expected to report earnings on Friday, October 30, 2026; the date is an estimate and has not been confirmed by the company. The consensus estimate is revenue of $7.60B.
How did IOLCP.BO do in its last earnings report?
In its most recent report on Aug 10, 2026, IOL Chemicals and Pharmaceuticals Limited posted EPS of $2.20. Revenue was $7.56B against a $6.47B estimate.
About IOL Chemicals and Pharmaceuticals Limited
IOL Chemicals and Pharmaceuticals Limited is a global manufacturer and supplier of a diverse range of pharmaceutical and chemical products. The company’s pharmaceutical portfolio focuses on Active Pharmaceutical Ingredients (APIs), providing essential compounds such as ibuprofen lysinate and ibuprofen sodium, alongside a variety of other APIs like metformin, fenofibrate, lamotrigine, clopidogrel bisulphate, pantoprazole, gabapentin, levetiracetam, and paracetamol. These APIs are utilized in medications designed for treatments spanning anti-inflammatory, analgesic, antipyretic, anti-diabetic, anti-platelet, anti-cholesterol, anti-convulsant, and anti-cholelithic purposes, as well as proton pump inhibition. Additionally, IOL offers specialty industrial chemicals, including ethyl acetate, iso butyl benzene, acetyl chloride, para amino phenol, and mono chloro acetic acid. These chemicals cater to a broad spectrum of industries, including food processing, flexible packaging, textiles, ink and paint production, pesticide manufacturing, and other chemical intermediate applications. Incorporated in 1986, IOL Chemicals and Pharmaceuticals Limited is based in Ludhiana, India.
🤖 AI Earnings Analysis
IOLCP.BO’s 31.4× P/E alongside a 5.94% profit margin leaves little room for earnings disappointment; no recent news or guidance data was provided.
AI-generated summary — powered by BigEarnings.
Earnings History
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-10 | — | 2.20 | — | $7.56B | — | — | — | — |
Showing last 1 quarters.